| Sign In to gain access to subscriptions and/or personal tools. |
From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link?Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Israel
Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Israel
Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Israel, Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel-Aviv University, Israel, shoenfel{at}post.tau.ac.il The heart lesions of rheumatic fever and the heart involvement in antiphospholipid syndrome (APS), have different clinical pictures. Yet, there are several common characteristics linking both diseases: 1) central nervous system (CNS) and heart involvement; 2) molecular mimicry between the a pathogen and the origin of the disease; 3) cross reacting antibodies between the pathogen and self molecules; 4) endothelial cell activation in the crime-area i.e., the valves; 5) some of the patients with RF have circulating antiphospholipid antibodies, while APS may be associated with streptococcal infection; and 6) recently, a cross-reactivity between antibodies directed to the streptococcal M-protein and its synthetic derivative in rheumatic fever (RF) and antibodies derived from APS patients targeting the beta-2-glycoprotein-I (ß2GPI) and a ß2GPI related synthetic peptide. In the current paper, we summarize the possible links between the heart involvement in RF and APS.
Key Words: anti-b2GPI antiphosphplipid syndrome autoimmunity Libman-Sacks endocarditis M-protein rheumatic fever
Lupus, Vol. 14, No. 9,
697-701 (2005) This article has been cited by other articles:
|
|||||||||||||||||||||||||||

